Table 1 Clinical characteristics of patients in the study
SCA patients (n = 23) | TEA patients (n = 23) | P Value | |
|---|---|---|---|
Age, mean (SD), y | 68 (6) | 63 (12) | .07 |
Sex, No. (%) | |||
Male | 17 (74) | 8 (35) | .01 |
Female | 6 (26) | 15 (65) | |
ASA-classification, No. (%) | |||
ASA-1 | 3 (13) | 0 | .19 |
ASA-2 | 14 (61) | 17 (74) | |
ASA-3 | 6 (26) | 6 (26) | |
Indication for surgery, No. (%) | |||
Diagnostic | 1 (4) | 3 (13) | .36 |
Malignant – Lung | 16 (70) | 17 (74) | |
Malignant – Metastasis | 6 (26) | 3 (13) | |
Tumour localization, No. (%) | |||
Right upper lobe | 9 (40) | 7 (30) | .83 |
Right middle lobe | 3 (13) | 2 (9) | |
Right lower lobe | 3 (13) | 5 (22) | |
Left upper lobe | 4 (17) | 6 (26) | |
Left lower lobe | 4 (17) | 3 (13) | |
Surgical technique, No. (%) | |||
VATS single-port | 4 (17) | 6 (26) | .48 |
VATS multi-port | 19 (83) | 17 (74) | |
Resection, No. (%) | |||
Wedge | 5 (22) | 7 (30) | .51 |
Segmentectomy | 1 (4) | 0 | |
Lobectomy | 16 (70) | 16 (70) | |
Bilobectomy | 1 (4) | 0 | |
Lymph node dissection, No. (%) | |||
None | 5 (22) | 6 (26) | .81 |
Ipsilateral hilair | 2 (8) | 3 (13) | |
Ipsilateral hilair + mediastinal | 16 (70) | 14 (61) | |
Surgery duration, mean (SD), min | 153 (52) | 130 (74) | .23 |